High materiality7/10
Rhythm Pharmaceuticals price target raised to $159 from $155 at RBC Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RYTM target raised to $159 from $155; current price $87.69; firm: RBC Capital; Analyst: Lisa Walter.
- Target: $159
- Posted price: $87.69
- Analyst: Lisa Walter
- Firm: RBC Capital
Key facts
- 01
Target: $159
- 02
Posted price: $87.69
- 03
Analyst firm: RBC Capital
- 04
Analyst: Lisa Walter
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.